factual
Atenolol Lowers BP But Not Outcomes
Atenolol (marketed as Tenormin) lowers blood pressure as well as most other antihypertensives, but pooled placebo-controlled studies show it does not improve mortality or heart attack risk and only slightly reduces stroke risk, illustrating that a drug can succeed on the surrogate endpoint yet fail on clinical endpoints.
factualpending
Speaker
Adam CifuEvidence Quote
“it doesn't improve mortality. Doesn't improve the risk of heart attacks.”
Created: 6/13/2026, 12:11:12 AM
Your notes
Loading notes...